Immediate-type hypersensitivity drug reactions
Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis
Impact of the reduction of calcineurin inhibitors on renal function in heart transplant patients: a systematic review and meta-analysis
New and emerging immune-targeted drugs for the treatment of multiple sclerosis
The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies
Association between nonsteroidal anti-inflammatory drug use and brain tumour risk: a meta-analysis
A phase II, randomized, placebo-controlled, double-blind, multi-dose study of SRT2104, a SIRT1 activator, in subjects with type 2 diabetes
Pharmacokinetics of oral vs . intravenous dexamethasone in patients hospitalized with community-acquired pneumonia
Moxifloxacin dosing in post-bariatric surgery patients
Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs . oral tablets
Model-based clinical pharmacology profiling of ipilimumab in patients with advanced melanoma
Relationship between inflammation and infliximab pharmacokinetics in rheumatoid arthritis
Effect of mushroom diet on pharmacokinetics of gabapentin in healthy Chinese subjects
Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance
Influence of covariate distribution on the predictive performance of pharmacokinetic models in paediatric research
Characterizing variability in warfarin dose requirements in children using modelling and simulation
Prevalence, nature and potential preventability of adverse drug events – a population-based medical record study of 4970 adults
Adverse effects and homeopathy: may remedies yet contain noxious or toxic molecules?
Evidence for harm, comment on ‘Use of benzodiazepines or benzodiazepine related drugs and the risk of cancer: a population-based case-control study’
Reply to ‘Evidence for harm, comment on …’ by Kripke & Langer
Misuse of the γ-aminobutyric acid analogues baclofen, gabapentin and pregabalin in the UK
Is combined use of SSRIs and NSAIDs associated with an increased risk of starting peptic ulcer treatment?